Chiome Bioscience Inc. (TYO:4583)
Japan · Delayed Price · Currency is JPY 105.00
+1.00 (0.96%)
At close: Mar 27, 2026
Chiome Bioscience Revenue
In the year 2025, Chiome Bioscience had annual revenue of 593.29M JPY, down -24.02%. Chiome Bioscience had revenue of 223.48M in the quarter ending December 31, 2025, a decrease of -37.61%.
Revenue
593.29M
Revenue Growth
-24.02%
P/S Ratio
12.29
Revenue / Employee
11.19M
Employees
53
Market Cap
7.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 593.29M | -187.52M | -24.02% |
| Dec 31, 2024 | 780.81M | 98.35M | 14.41% |
| Dec 31, 2023 | 682.46M | 51.65M | 8.19% |
| Dec 31, 2022 | 630.82M | -82.12M | -11.52% |
| Dec 31, 2021 | 712.93M | 232.08M | 48.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Linical | 9.32B |
| Soiken Holdings | 4.58B |
| CellSource | 3.72B |
| StemCell Institute | 2.78B |
| MEDINET | 998.00M |
| OncoTherapy Science | 784.00M |
| PRISM BioLab Co.,LTD | 684.61M |
| Carna Biosciences | 579.06M |